FTC settles pay-for-delay lawsuit, files two related complaints

WASHINGTON (Reuters) - The U.S. Federal Trade Commission said on Monday it had settled allegations that Endo Pharmaceuticals violated antitrust law when it agreed to pay rivals Watson Laboratories and Impax to delay introducing generic versions of two painkillers.